2 recruiting, 1 completed, 1 terminated, 1 unknown. 5 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 5 | Recruiting 2, Completed 1, Terminated 1, Unknown 1 |
Follow Chronic Lymphocytic Leukemia (CLL): new trials by email Literature Review of Chronic Lymphocytic Leukemia (CLL) trials Research Report on Chronic Lymphocytic Leukemia (CLL)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib Pirtobrutinib - Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) | Early Phase 1 | Recruiting | National Heart, Lung, and Blood Institute (NHLBI) | 30 | 2026-03-11 | 2026-10-22 |
| A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia GT801 Injection - B-cell Acute Lymphoblastic Leukemia (B-ALL), Chronic Lymphocytic Leukemia (CLL) | Early Phase 1 | Recruiting | Grit Biotechnology | 28 | 2025-09-26 | 2026-07-20 |
| Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies CT125A cells, Cyclophosphamide, fludarabine - CD5+ Relapsed/Refractory Hematopoietic Malignancies, Chronic Lymphocytic Leukemia (CLL) | Early Phase 1 | Unknown | Huazhong University of Science and Technology | 18 | 2021-03-01 | 2021-02-23 |
| Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors Shingrix vaccine - Chronic Lymphocytic Leukemia (CLL), Waldenstrom Macroglobulinemia (WM) | Early Phase 1 | Completed | University of Rochester | 33 | 2019-02-01 | 2024-03-15 |
| A Study of the Effect of Vinca Alkaloids on c-Jun N-terminal Kinase (JNK) Phosphorylation in Patients With Chronic Lymphocytic Leukemia (CLL) vincristine - Chronic Lymphocytic Leukemia (CLL) | Early Phase 1 | Terminated | Dartmouth-Hitchcock Medical Center | 11 | 2012-10-01 | 2015-05-12 |
Leukemia, Lymphocytic, Chronic, B-Cell (5) · Anemia, Hemolytic, Autoimmune (1) · Burkitt Lymphoma (1) · Hematologic Neoplasms (1) · Leukemia, B-Cell (1) · Lymphoma, B-Cell (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, T-Cell, Peripheral (1) · Waldenstrom Macroglobulinemia (1)
Chronic Disease (5) · Disease Attributes (5) · Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Immune System Diseases (5) · Immunoproliferative Disorders (5) · Leukemia (5) · Leukemia, Lymphoid (5) · Lymphatic Diseases (5) · Lymphoproliferative Disorders (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Leukemia, B-Cell (4)
CF regimen (1) · Vincristine (1) · pirtobrutinib (1)
Dartmouth-Hitchcock Medical Center (1) · Grit Biotechnology (1) · Huazhong University of Science and Technology (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · University of Rochester (1)
United States (3) · China (1)
Alexey V Danilov, MD (1) · Jianfeng Zhou, PhD, MD (1) · Jonathan Friedberg, MD (1) · Laura S Samples, M.D. (1)